Papers on COVID-19 and CML/cancer - 2020

December 2020

• Tyrosine kinase inhibitors and COVID-19
  Semih B et al. J Oncol Pharm Pract, December 2020
• Outcomes of patients with haematological malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
  Wood WA et al. Blood Adv, December 2020 – open access publication
• The management of hematologic malignancies during the COVID-19 pandemic
  Hus I et al. Expert Opin Pharmacother, December 2020 (epub ahead of print)
• Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with haematological malignancies
  Borah P et al. Blood Cell Mol Dis, December 2020 (epub ahead of print) - open access publication
• How we have protected our patients: The Italian pediatric onco-hematology unit’s response to the COVID-19 pandemic
  Amicucci M et al. Pediatr Blood Cancer, December 2020 – open access publication

November 2020

• Outcome of hospitalized patients with haematological malignancies and COVID-19 infection in a large urban healthcare trust in the UK
  Garnett C et al. Leuk Lymphoma, November 2020 (epub ahead of print)
• High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort study
  Elkrief A et al. Eur J Cancer, November 2020 – open access publication
• COVID-19 severity and outcomes in patients with cancer: A matched cohort study
  Brar G et al. J Clin Oncol, November 2020

October 2020

• Impact of hematologic malignancies and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
  García-Suárez J et al. J Hematol Oncol, October 2020 – open access publication
• An online tool for predicting the prognosis of cancer patients with SARS-CoV2 infection: a multi-centre study
  Song C et al. J Cancer Res Clin Oncol, October 2020 – open access publication
• Cancer and COVID-19
  Malek AE et al. Lancet Oncol, October 2020 – open access publication
• Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
  Currigliano G et al. Ann Oncol, October 2020 - open access publication

September 2020

• Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19
  Cattaneo C et al. Cancer, September 2020 (epub ahead of print)
  – open access publication
• Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and The Netherland
  Van Doesum J et al. Leukemia, September 2020 – open access publication

August 2020

• Risk factors and outcome of COVID-19 in patients with haematological malignancies
  Piñana JL et al. Exp Hematol Oncol, August 2020 – open access publication
• COVID-19 in haematological malignancy patients: A protocol for a systemic review and meta-analysis
  Chen C et al. Medicine (Baltimore), August 2020 – open access publication
• COVID-19 in children with blood and cancer disorders: What do we know so far?
  Yadar SP. J Pediatr Hematol Oncol, August 2020
• Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
  Basci S et al. J Oncol Pharm Pract, August 2020
• COVID-19 in patients with haematological malignancies: A retrospective case series
  Infante MS et al. Int J Lab Hematol, August 2020 (epub ahead of print)
  – open access publication
• The outcome of COVID-19 in patients with haematological malignancy
  Yigenoglu TN et al. J Med Virol, August 2020 (epub ahead of print)
  – open access publication
• Clinical characteristics and risk factors associated with COVID-10 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
  Passamonti F et al. Lancet Haematol, August 2020 (epub ahead of print)
  – open access publication
• Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-10 inpatients with haematological malignancies
  Wu Y et al. Leuk Lymphoma, August 2020 (epub ahead of print)

July 2020

• SARS CoV2 infection in chronic myelogenous leukemia: Severe haematological presentation
  Sorà F et al. Transfus Apher Sci, July 2020 (epub ahead of print)
  – open access publication
• Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic: A prospective cohort study
  Ector GICG et al. Leukemia, July 2020 (epub ahead of print)
  - open access publication
• Survival study of hospitalized patients with concurrent COVID-19 and haematological malignancies
  Martín-Moro F et al. Br J Haematol, July 2020 – open access publication
• Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies
  Sanchez-Pina JM et al. Eur J Haematol, July 2020 (epub ahead of print)
• COVID-19 in post transplant patients – report of 2 cases
  Huang J et al. Am J Transplant, July 2020 – open access publication

June 2020

• Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King’s College Hospital experience
  Shah V et al. Br J Haematol, June 2020 (epub ahead of print)
  – open access publication
• Haematological cancers and risk of severe COVID-19: Exploration and critical evaluation of the evidence to date
  El-Sharkawi D et al. Br J Haematol, June 2020 (epub ahead of print)
  - open access publication
• Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
  Breccia M et al. Leukemia, June 2020 (epub ahead of print) - open access publication
• Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukemia
  Ranger A et al. Br J Haematol, June 2020 (epub ahead of print) - open access publication
• Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structural summary of a study protocol for a randomized controlled trial
  Allahyari A et al. Trials, June 2020 – open access publication
• COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
  Lee LYW et al. Lancet, June 2020 – open access publication
• Managing hematology and oncology patients during the COVID-19 pandemic: Interim consensus guidance
  Weinkove R et al. Med J Aust, June 2020 – open access publication
• Janus faced course of COVID-10 infection in patients with hematological malignancies
  Bellmann-Weiler R et al. Eur J Haematol, June 2020 – open access publication
• Managing patients with hematological malignancies during COVID-19 pandemic
  Sahu KK and Cerny J. Expert Rev Hematol, June 2020 (epub ahead of print)
• Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis
  Meng Y et al. Version 2. J Hematol Oncol, June 2020 – open access publication
• A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An international Collaborative Group
  Al-Shamsi HO et al. Oncologist, June 2020 – open access publication

May 2020

• Frequently asked questions regarding SARS-CoV-2 in cancer patients – recommendations for clinicians caring for patient with malignant diseases
  von Lilienfeld-Toal M et al. Leukemia, May 2020 (epub ahead of print)
  - open access publication
• Two false-negative test results in a symptomatic patient with a confirmed case of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and suspected Stevens-Johnson Syndrome / toxic epidermal necrolysis (SJS/TEN)
  Langziel T et al. Cureus, May 2020 – open access publication
• COVID-19 in persons with chronic myeloid leukaemia
  Li W et al. Leukemia, May 2020 (epub ahead of print) - open access publication
• COVID-19 and cancer: A comprehensive review
  Gosain R et al. Curr Oncol Rep, May 2020 - open access publication
• SARS-CoV-2 (COVID-19) and chronic myeloid leukemia (CML): a Case Report and Review of ABL kinase involvement in viral infection
  Abruzzese E et al. Mediterr J Hematol Infect Dis, May 2020 - open access publication
• Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID-19 pandemic
  Eskazan AE et al. Br J Clin Pharmacol, May 2020 (epub ahead of print) - open access publication
• Treating leukemia in the time of COVID-19
  Paul S et al. Acta Haematol, May 2020 (epub ahead of print) - open access publication
• The CoV-2 outbreak: how hematologists could help to fight COVID-19
  Galimberti S et al. Pharmacol Res, May 2020 (epub ahead of print) - open access publications
• Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomized, phase 2 trial
  Hung IF et al. The Lancet, May 2020 – open access publication
• Successful prevention and screening strategies for COVID-19: focused on patients with hematological diseases
  Cho SY et al. Br J Haematol, May 2020 - open access publication

April 2020

• Hematology in the time of COVID-19
  Gavillet M et al. Rev Med Suisse, April 2020 (in French)
• COVID-19 in persons with hematological cancers
  He W et al. Leukemia, April 2020 (epub ahead of print)
• Effect of the COVID-19 pandemic on cancer treatment and research
  Saini KS et al. Lancet Haematol, April 2020 (epub ahead of print)
• What the oncologist needs to learn about COVID-19 infection in cancer patients
  Rassy E et al. Future Oncol, April 2020 (epub ahead of print) - open access publication

March 2020

• The first report of the prevalence of COVID-19 in chronic myelogenous leukemia patients in the core epidemic area of China: multicentre, cross-sectional survey
  Wang DY et al. MedRxix, March 2020 (epub ahead of print) - open access publication
• Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
  Liang W et al. Lancet Oncol, March 2020 - open access publication
• Coronavirus disease COVID-19: EBMT recommendations update March 23, 2020
  European Society for Blood and Marrow Transplantation (EBMT), March 2020 - open access publication

March 2018

• Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors
  Journal of General Virology 2018;99:619–630 - open access publication
  
  

Papers on COVID-19

• April 2020

  • Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory diseases syndrome in Korea
    Ahn JY et al. J Korean Med Sci, April 2020 - open access publication
  • Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
    Xu Y et al. Nat Med, April 2020 - open access publication

  March 2020

  • COVID-19 and the cardiovascular system
    Zheng YY et al. Nat Rev Cardiol, March 2020 (epub ahead of print) - open access publication
  • Challenges of coronavirus disease 2019
    Lancet Infect Dis, March 2020 - open access publication

  February 2020

  • Clinical characteristics of coronavirus disease 2019 in China
    Guan W et al. N Eng J Med, February 2020 - open access publication
  • Q&A: The novel coronavirus outbreak causing COVID-19
    Fisher D & Heymann D et al. BMC Medicine, February 2020 - open access publication
  • Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies
    Ahmed SF et al. Viruses, February 2020 - open access publication
  • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
    Huang C et al. Lancet, February 2020 - open access publication
  • Update: Public health responses to the coronavirus disease 2019 outbreak - United States, February 24, 2020
    Jernigan DB & CDC COVID-19 Response Team, MMWR Morb Mortal Wkly Rep, February 2020
    - open access publication
  • Coronavirus disease 2019 (COVID-19) and pregnancy: What obstetricians need to know
    Rasmussen SA et al. Obstet Gynecol, February 2020 (epub ahead of publication) - open access publication
  • The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020
    The novel Coronavirus Pneumonia Emergency Response Epidemiology Team, Center of Disease Control (CDC) China Weekly